Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Verneris

Showing results (21-30 of 201) with videos related to

Pageof 21
Sort By:
Journal for Immunotherapy of Cancer|April 13, 2021
Perspectives on outpatient administration of CAR-T cell therapy in aggressive B-cell lymphoma and acute lymphoblastic leukemiaG Doug Myers, Michael R Verneris, Andre Goy, et al.
Frontiers in Oncology|December 31, 2020
Targeting Tumor-Associated Macrophages in the Pediatric Sarcoma Tumor MicroenvironmentJane Koo, Masanori Hayashi, Michael R Verneris, et al.
Blood|January 19, 2013
Lineage relationships of human interleukin-22-producing CD56+ RORγt+ innate lymphoid cells and conventional natural killer cellsYong-Oon Ahn, Bruce R Blazar, Jeffrey S Miller, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 10, 2013
Allogeneic hematopoietic cell transplantation in first remission abrogates poor outcomes associated with high-risk pediatric acute myeloid leukemiaMichael J Burke, John E Wagner, Qing Cao, et al.
Blood|January 31, 2009
Prolonged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantationVeronika Bachanova, Michael R Verneris, Todd DeFor, et al.
Immunological Reviews|February 13, 2014
The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT)Bree Foley, Martin Felices, Frank Cichocki, et al.
Expert Review of Proteomics|August 12, 2006
Studying multiple protein profiles over time to assess biomarker validityRaj S Kasthuri, Michael R Verneris, Hassan N Ibrahim, et al.
Blood|April 9, 2004
Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cellsMichael R Verneris, Mobin Karimi, Mobin Karami, et al.
Blood|December 22, 2010
Natural killer-cell differentiation by myeloid progenitorsBartosz Grzywacz, Nandini Kataria, Niketa Kataria, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 20, 2017
Impact of Delayed Infusion Time in Umbilical Cord Blood TransplantationRichard Mitchell, John E Wagner, Claudio Brunstein, et al.
Pageof 21

Showing results (21-30 of 201) with videos related to

Sort By:
Pageof 21
Journal for Immunotherapy of Cancer|April 13, 2021
Perspectives on outpatient administration of CAR-T cell therapy in aggressive B-cell lymphoma and acute lymphoblastic leukemiaG Doug Myers, Michael R Verneris, Andre Goy, et al.
Frontiers in Oncology|December 31, 2020
Targeting Tumor-Associated Macrophages in the Pediatric Sarcoma Tumor MicroenvironmentJane Koo, Masanori Hayashi, Michael R Verneris, et al.
Blood|January 19, 2013
Lineage relationships of human interleukin-22-producing CD56+ RORγt+ innate lymphoid cells and conventional natural killer cellsYong-Oon Ahn, Bruce R Blazar, Jeffrey S Miller, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 10, 2013
Allogeneic hematopoietic cell transplantation in first remission abrogates poor outcomes associated with high-risk pediatric acute myeloid leukemiaMichael J Burke, John E Wagner, Qing Cao, et al.
Blood|January 31, 2009
Prolonged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantationVeronika Bachanova, Michael R Verneris, Todd DeFor, et al.
Immunological Reviews|February 13, 2014
The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT)Bree Foley, Martin Felices, Frank Cichocki, et al.
Expert Review of Proteomics|August 12, 2006
Studying multiple protein profiles over time to assess biomarker validityRaj S Kasthuri, Michael R Verneris, Hassan N Ibrahim, et al.
Blood|April 9, 2004
Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cellsMichael R Verneris, Mobin Karimi, Mobin Karami, et al.
Blood|December 22, 2010
Natural killer-cell differentiation by myeloid progenitorsBartosz Grzywacz, Nandini Kataria, Niketa Kataria, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 20, 2017
Impact of Delayed Infusion Time in Umbilical Cord Blood TransplantationRichard Mitchell, John E Wagner, Claudio Brunstein, et al.
Pageof 21